Evidence map›Paper›PMID 35012662›Full record

ArticleCritical care (London, England)2022

Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study.

Jessica González, Iván D Benítez, David de Gonzalo-Calvo, Gerard Torres, Jordi de Batlle, Silvia Gómez, Anna Moncusí-Moix, Paola Carmona, Sally Santisteve, Aida Monge and 22 more

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 5 institutions in 2 countries.

Jessica GonzálezPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Iván D BenítezTranslational Research in Respiratory Medicine Group (TRRM), Lleida, Spain.
David de Gonzalo-CalvoTranslational Research in Respiratory Medicine Group (TRRM), Lleida, Spain.
Gerard TorresPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Jordi de BatlleTranslational Research in Respiratory Medicine Group (TRRM), Lleida, Spain.
Silvia GómezPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Anna Moncusí-MoixTranslational Research in Respiratory Medicine Group (TRRM), Lleida, Spain.
Paola CarmonaPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Sally SantistevePulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Aida MongePulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Clara Gort-PanielloTranslational Research in Respiratory Medicine Group (TRRM), Lleida, Spain.
María ZuilPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Ramón Cabo-GambínPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Carlos Manzano SenraPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
José Javier Vengoechea AragoncilloPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Rafaela VacaPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Olga MinguezPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
María AguilarPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain.
Ricard FerrerCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Adrián CeccatoCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Laia FernándezCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Ana MotosCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Jordi RieraCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Rosario MenéndezCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Darío Garcia-GasullaBarcelona Supercomputing Center (BSC), Barcelona, Spain.
Oscar PeñuelasCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Gonzalo LabarcaFaculty of Medicine, University of Concepcion, Concepción, Chile.
Jesús CaballeroIntensive Care Department, Hospital Universitari Arnau de Vilanova de Lleida, IRBLleida, Lleida, Spain.
Carme BarberàIntensive Care Department, Hospital Universitari Santa Maria de Lleida, Lleida, Spain.
Antoni TorresCIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Ferran BarbéPulmonary Department, Hospital Universitari Arnau de Vilanova and Santa Maria, Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain. febarbe.lleida.ics@gencat.cat.
CIBERESUCICOVID Project (COV20/00110, ISCIII)
Instituto de Salud Carlos III · ESHospital Universitari Arnau de Vilanova · ESBarcelona Supercomputing Center · ESUniversity of Concepción · CLHospital Universitari de Santa Maria · ES

Funding

Instituto de Salud Carlos III CIBERESUCICOVIDInstituto de Salud Carlos III COV20/00110Instituto de Salud Carlos III CP19/00108Instituto de Salud Carlos III CP20/00041
6 · The paper itself

Abstract

questionWe evaluated whether the time between first respiratory support and intubation of patients receiving invasive mechanical ventilation (IMV) due to COVID-19 was associated with mortality or pulmonary sequelae. MATERIALS AND

methodsProspective cohort of critical COVID-19 patients on IMV. Patients were classified as early intubation if they were intubated within the first 48 h from the first respiratory support or delayed intubation if they were intubated later. Surviving patients were evaluated after hospital discharge.

resultsWe included 205 patients (140 with early IMV and 65 with delayed IMV). The median [p

conclusionsAmong critically ill patients with COVID-19 who required IMV, the delay in intubation from the first respiratory support was associated with an increase in hospital mortality and worse pulmonary sequelae during follow-up.

Indexed as

COVID-19Critical IllnessAgedHumansIntubation, IntratrachealMaleProspective StudiesRespiration, ArtificialSARS-CoV-2ARDSCOVID-19Critically ill patientsEarly intubationPulmonary sequelaeRespiratory management

Identifiers

PMID35012662
PMCPMC8744383
OpenAlexW4205975800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.